NCT05898763 2024-11-07
TEIPP
Erasmus Medical Center
Phase 1/2 Completed
Clinical Trials
4 trialsNCT03617328 2024-02-06
Mel-65
University of Virginia
Phase 1/2 Completed
NCT00089219 2014-11-20
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
University of Virginia
Phase 1/2 Completed
NCT00004918 2013-01-07
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 1/2 Completed